Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.
Bisecco A, Matrone F, Capobianco M, De Luca G, Filippi M, Granella F, Lus G, Marfia GA, Mirabella M, Patti F, Trojano M, Mascolo A, Copetti M, Tedeschi G, Gallo A; OCREVID study group on behalf of the Italian MS Register. Bisecco A, et al. J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20. J Neurol. 2024. PMID: 37982852 Free PMC article.
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.
Smolik K, Camilli F, Panzera I, Fiore A, Franceschini A, Foschi M, Surcinelli A, Pesci I, Ferri C, Bazzurri V, Mancinelli L, Zini C, Simone AM, Lugaresi A, Falzone F, Granella F, Piscaglia MG, Guareschi A, Baldi E, Immovilli P, Montepietra S, Santangelo M, Poma N, Cardi M, De Napoli G, Vitetta F, Ferraro D. Smolik K, et al. Among authors: franceschini a. Mult Scler Relat Disord. 2024 Nov 24;93:106191. doi: 10.1016/j.msard.2024.106191. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39616774 Free article.
HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients.
Talarico G, Franceschini A, Raveane A, Falvo P, Mazzara S, Melle F, Motta G, Orecchioni S, Tenore A, Gregato G, Poletti C, Chiarle R, Pileri S, Mancuso P, Bertolini F. Talarico G, et al. Among authors: franceschini a. Discov Oncol. 2024 Dec 18;15(1):764. doi: 10.1007/s12672-024-01657-y. Discov Oncol. 2024. PMID: 39692827 Free PMC article.
Preoperative Briganti Nomogram Score and Risk of Prostate Cancer Progression After Robotic Surgery Beyond EAU Risk Categories.
Porcaro AB, Orlando R, Panunzio A, Tafuri A, Baielli A, Artoni F, Brancelli C, Roggero L, Costantino S, Franceschini A, Boldini M, Treccani LP, Montanaro F, Gallina S, Bianchi A, Serafin E, Mazzucato G, Ditonno F, Finocchiaro M, Veccia A, Rizzetto R, Brunelli M, De Marco V, Siracusano S, Cerruto MA, Bertolo R, Antonelli A. Porcaro AB, et al. Among authors: franceschini a. Medicina (Kaunas). 2024 Oct 27;60(11):1763. doi: 10.3390/medicina60111763. Medicina (Kaunas). 2024. PMID: 39596948 Free PMC article.
The 2012 Briganti nomogram predicts disease progression after surgery in high-risk prostate cancer patients.
Porcaro AB, Panunzio A, Orlando R, Tafuri A, Gallina S, Bianchi A, Serafin E, Mazzucato G, Montanaro F, Baielli A, Artoni F, Ditonno F, Roggero L, Franceschini A, Boldini M, Treccani LP, Veccia A, Rizzetto R, Brunelli M, De Marco V, Siracusano S, Cerruto MA, Bertolo R, Antonelli A. Porcaro AB, et al. Among authors: franceschini a. Arab J Urol. 2024 Apr 8;22(4):227-234. doi: 10.1080/20905998.2024.2339062. eCollection 2024. Arab J Urol. 2024. PMID: 39355796 Free PMC article.
Outcomes of da Vinci® versus Hugo RAS® radical prostatectomy: focus on postoperative course, pathological findings, and patients' health-related quality of life after 100 consecutive cases (the COMPAR-P prospective trial).
Antonelli A, Veccia A, Malandra S, Rizzetto R, Artoni F, Fracasso P, Fumanelli F, Palumbo I, Raiti A, Roggero L, Treccani LP, Vetro V, DE Marco V, Porcaro AB, Cerruto MA, Brunelli M, Bertolo R; Residency Program in Urology at the University of Verona. Antonelli A, et al. Minerva Urol Nephrol. 2024 Oct;76(5):596-605. doi: 10.23736/S2724-6051.24.05928-7. Minerva Urol Nephrol. 2024. PMID: 39320250 Clinical Trial.
Briganti's 2012 nomogram is an independent predictor of prostate cancer progression in EAU intermediate-risk class: results from 527 patients treated with robotic surgery.
Porcaro AB, Montanaro F, Baielli A, Artoni F, Brancelli C, Costantino S, Franceschini A, Gallina S, Bianchi A, Serafin E, Veccia A, Rizzetto R, Brunelli M, Migliorini F, Siracusano S, Cerruto MA, Bertolo RG, Antonelli A. Porcaro AB, et al. Among authors: franceschini a. Asian J Androl. 2024 Nov 1;26(6):587-591. doi: 10.4103/aja202439. Epub 2024 Jul 30. Asian J Androl. 2024. PMID: 39075792 Free PMC article.
128 results